Disease Pharmacology

Disease Pharmacology is a core component of groundbreaking drug development and disease models provide a critical path to drug discovery success. These models provide invaluable study endpoints, guide research efforts, and drive decision making for innovative therapeutic interventions. Inotiv has established and provides access to a wide range of in vivo, preclinical early-stage research models combined with drug efficacy, pharmacology, and safety studies.

Inotiv’s experienced team of scientists has the expertise to offer a wide range of study designs in pharmacology and toxicology within multiple therapeutic and disease indications including neuroscience, GI/IBD, inflammatory/immunology, cardio-renal, hepatic, pulmonary disease, and more. Their hands-on collaborative approach means that our scientists will work with you to learn your specific preclinical study requirements and assist you from initial study design to final reporting with dependable, reproducible results.